http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0829262-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
filingDate 1997-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1998-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0829262-A3
titleOfInvention Use of PKC inhibitors for the manufacture of a medicament for the treatment of sexual dysfunctions
abstract A method for treating sexual dysfunctions is disclosed, particularly using thenisozyme selective PKC inhibitor, (S)-3,4-[N, N'-1,1'-((2"-ethoxy)-3‴(O)-4‴-(N,N-dimethylamino)-butane)-bis-(3,3'-indolyl)]-1(H)-pyrrole-2,5-dione,nparticularly itsnhydrochloride, or mesylate salt.
priorityDate 1996-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0657458-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10687637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129709395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129706911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128420332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128529382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129398695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128186503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127956138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128179506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129598381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127692250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128964042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128784833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128438809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129580632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129331166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129845237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129025877

Total number of triples: 56.